BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe

  September 28, 2015

   · 

  24 min read
• Deals

  ACETO Subsidiary, Rising Pharmaceuticals, Inc, Acquires Three FDA-Approved ANDAs From Endo International

  September 28, 2015

   · 

  4 min read
• Drug Development

  Cellular Biomedicine Group Announces Positive Results From CAR-T EGFR Immunotherapy In Advanced Relapsed/Refractory Patients With Solid Tumors

  September 28, 2015

   · 

  8 min read
• Drug Development

  OncoGenex Presents Additional Phase 3 SYNERGY Analyses Showing Custirsen Significantly Reduced Serum Clusterin Levels In Metastatic Prostate Cancer Patients; Low Levels Correlate With Improved Survival In Those At Increased Risk For Poor Outcomes

  September 28, 2015

   · 

  9 min read
• Drug Development

  Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial Of VTS-270 For Treatment Of Niemann-Pick Type C1 (NPC) Disease

  September 28, 2015

   · 

  5 min read
• Drug Development

  Novartis AG Drug Afinitor Significantly Improves Progression-Free Survival In Advanced Nonfunctional Gastrointestinal And Lung NET

  September 28, 2015

   · 

  11 min read
• Biotech Bay

  Thoratec Release: HeartMate 3 CE Mark Trial Meets Primary Endpoint

  September 28, 2015

   · 

  6 min read
• Drug Development

  VBL Therapeutics Reports Full Phase 2 Data From Clinical Trial Of VB-111 In Recurrent Glioblastoma (rGBM) At The ECC 2015 Conference, Meeting The Primary Endpoint Of Statistically-Significant Increase In Overall Survival

  September 28, 2015

   · 

  7 min read
• Drug Development

  Vital Therapies Outlines Plans For New Phase 3 Trial Of ELAD In Alcohol-Induced Liver Decompensation

  September 28, 2015

   · 

  7 min read
• New customizable NASASTENT Nasal Dressing From Smith & Nephew Inc. Designed To Dissolve Completely

  September 28, 2015

   · 

  4 min read